Gsa Capital Partners LLP Verrica Pharmaceuticals Inc. Transaction History

Gsa Capital Partners LLP

  • $1.43 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 16, 2024
BUY
$2.93 - $7.32 $44,922 - $112,230
15,332 Added 66.05%
38,546 $282,000
Q3 2023

Nov 15, 2023
SELL
$3.75 - $7.46 $56,077 - $111,556
-14,954 Reduced 39.18%
23,214 $90,000
Q2 2023

Aug 14, 2023
BUY
$5.32 - $6.79 $203,053 - $259,160
38,168 New
38,168 $220,000
Q3 2021

Nov 12, 2021
SELL
$9.55 - $13.96 $890,623 - $1.3 Million
-93,259 Closed
0 $0
Q2 2021

Aug 05, 2021
BUY
$9.77 - $15.33 $911,140 - $1.43 Million
93,259 New
93,259 $1.05 Million

Others Institutions Holding VRCA

# of Institutions
71
Shares Held
17.4M
Call Options Held
6.1K
Put Options Held
6.3K
View Full List

About Verrica Pharmaceuticals Inc.

VRCA Quotes by TradingView
  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email